Atlas Antibodies

Executive Summary

Atlas Antibodies, founded in 2006 in Sweden, is a biotechnology company that develops and provides highly validated antibodies and multiplexing assays for protein research. Originating from the Human Protein Atlas project, the company focuses on creating research tools for scientists by scientists, with a mission to advance protein research globally. Its products are designed to support researchers and clinicians in next-generation protein analysis, leveraging the extensive knowledge and resources from the Human Protein Atlas to ensure high specificity and reproducibility. The company operates in the competitive antibodies market but differentiates itself through its strong validation standards and direct connection to the Human Protein Atlas. As a private entity, Atlas Antibodies has the potential for growth through expansion of its product portfolio and strategic partnerships. However, limited public information on financials or recent developments makes it difficult to assess its market traction. The company's focus on high-quality research tools positions it well in the life science tools sector, but achieving significant scale may require additional funding or commercial partnerships.

Upcoming Catalysts (preview)

• TBDLaunch of New Multiplex Protein Assays60% success
• TBDStrategic Partnership with Major Research Institute50% success
• TBDSeries A or B Funding Round45% success